Your browser doesn't support javascript.
loading
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu, Feng-Cai; Wurie, Alie H; Hou, Li-Hua; Liang, Qi; Li, Yu-Hua; Russell, James B W; Wu, Shi-Po; Li, Jing-Xin; Hu, Yue-Mei; Guo, Qiang; Xu, Wen-Bo; Wurie, Abdul R; Wang, Wen-Juan; Zhang, Zhe; Yin, Wen-Jiao; Ghazzawi, Manal; Zhang, Xu; Duan, Lei; Wang, Jun-Zhi; Chen, Wei.
Afiliação
  • Zhu FC; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Wurie AH; Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Hou LH; Beijing Institute of Biotechnology, Beijing, China.
  • Liang Q; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Li YH; National Institute for Food and Drug Control, Beijing, China.
  • Russell JB; Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Wu SP; Beijing Institute of Biotechnology, Beijing, China.
  • Li JX; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Hu YM; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Guo Q; Beijing Institute of Biotechnology, Beijing, China.
  • Xu WB; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wurie AR; Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Wang WJ; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Zhang Z; Beijing Institute of Biotechnology, Beijing, China.
  • Yin WJ; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ghazzawi M; Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Zhang X; Tianjin CanSino Biotechnology, Tianjin, China.
  • Duan L; Tianjin CanSino Biotechnology, Tianjin, China.
  • Wang JZ; National Institute for Food and Drug Control, Beijing, China. Electronic address: wangjz@nicpbp.org.cn.
  • Chen W; Beijing Institute of Biotechnology, Beijing, China. Electronic address: cw0226@foxmail.com.
Lancet ; 389(10069): 621-628, 2017 02 11.
Article em En | MEDLINE | ID: mdl-28017399
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China